donitriptan has been researched along with phenylephrine in 1 studies
| Studies (donitriptan) | Trials (donitriptan) | Recent Studies (post-2010) (donitriptan) | Studies (phenylephrine) | Trials (phenylephrine) | Recent Studies (post-2010) (phenylephrine) |
|---|---|---|---|---|---|
| 13 | 0 | 4 | 13,797 | 857 | 2,083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Centurión, D; Gupta, S; Jiménez-Mena, LR; Lozano-Cuenca, J; MaassenVanDenBrink, A; Mehrotra, S; Muñoz-Islas, E; Sánchez-López, A; Villalón, CM | 1 |
1 other study(ies) available for donitriptan and phenylephrine
| Article | Year |
|---|---|
Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors.
Topics: Acetylcholine; Animals; Benzopyrans; Calcitonin Gene-Related Peptide; Capsaicin; Carotid Artery, External; Chromans; Dogs; Dose-Response Relationship, Drug; Hemodynamics; Humans; In Vitro Techniques; Infusions, Intravenous; Nitriles; Phenylephrine; Piperazines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vasoconstrictor Agents; Vasodilation | 2006 |